SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SCIO Scios Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (953)12/29/1998 2:32:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 1477
 
<If it is not drug related, than why it was discontinued? No benefit?>

MZ, I see your point. The safety committee clearly felt there was at least the potential that the adverse events were drug related.

Since the CAD and PVD Phase II trials have been running for almost a year, I agree that the upcoming H&Q conference would be a superb forum to present at least preliminary results!

Rudy